Last checked at 31 Aug 2016 16:49
31 August 2016
Assura plc
Exercise of Nil Cost Options under VCP
Assura plc ("Assura"), the leading primary care property investor and developer announces that on 30 August 2016, all PDMRs and staff exercised the element of their awards (25% by number) of the Assura Group Value Creation Plan ("VCP") which were exercisable under the Rules of the VCP. The remaining nil cost options are exercisable subject to the achievement of performance hurdles in 2017.
The table below shows the number of nil cost options exercised by PDMRs, the number of shares sold to satisfy Income Tax and National Insurance liabilities and the number of shares they will receive following the sale to satisfy Income Tax and national insurance liabilities.
| Number of Nil Cost Options exercised | Number of shares sold to satisfy Income Tax and National Insurance liabilities | Number of shares receivable after sale to satisfy Income Tax and National Insurance |
Jonathan Murphy (Finance Director) | 1,288,356 | (605,527) | 682,829 |
Andrew Darke | 1,472,407 | (692,031) | 780,376 |
The Remuneration Committee of Assura had previously agreed that sufficient shares may be sold by PDMRs to cover the arising Income Tax and National Insurance liabilities. The relevant market price for taxation purposes is 58.65 pence per share being the mid-market price at close of business on 26 August.
As a result of the above, the increases in the shareholdings of the PDMRs are as follows:
| Shareholding on 29 August 2016 | Shareholding post exercise |
Jonathan Murphy (Finance Director) | 957,517 | 1,640,346 |
Andrew Darke | 378,739 | 1,159,115 |
The Notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name
| Jonathan Murphy | ||||
2 | Reason for the notification
| |||||
a) | Position/status
| Finance Director | ||||
b) | Initial notification/ Amendment
| Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a) | Name
| Assura plc | ||||
b) | LEI
| N/A | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||
b) | Nature of the transaction
|
Vesting of share awards under VCP
| ||||
c) | Price(s) and volume(s)
|
| ||||
d) | Aggregated information
- Aggregated volume
- Price
|
N/A | ||||
e) | Date of the transaction
| 30 August 2016 | ||||
f) | Place of the transaction
| XLON | ||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||
b) | Nature of the transaction
| Sale of 605,527 shares to satisfy tax and national insurance liabilities.
| ||||
c) | Price(s) and volume(s)
|
| ||||
d) | Aggregated information
- Aggregated volume
- Price
|
N/A | ||||
e) | Date of the transaction
| 31 August 2016 | ||||
f) | Place of the transaction
| XLON | ||||
1 | Details of the person discharging managerial responsibilities/person closely associated
| |||||
a) | Name
| Andrew Darke | ||||
2 | Reason for the notification
| |||||
a) | Position/status
| Property Director | ||||
b) | Initial notification/ Amendment
| Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a) | Name
| Assura plc | ||||
b) | LEI
| N/A | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||
b) | Nature of the transaction
|
Vesting of share awards under VCP
| ||||
c) | Price(s) and volume(s)
|
| ||||
d) | Aggregated information
- Aggregated volume
- Price
|
N/A | ||||
e) | Date of the transaction
| 30 August 2016 | ||||
f) | Place of the transaction
| XLON | ||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 10 pence each
GB00BVGBWW93 | ||||
b) | Nature of the transaction
| Sale of 692,031 shares to satisfy tax and national insurance liabilities.
| ||||
c) | Price(s) and volume(s)
|
| ||||
d) | Aggregated information
- Aggregated volume
- Price
|
N/A | ||||
e) | Date of the transaction
| 31 August 2016 | ||||
f) | Place of the transaction
| XLON | ||||
- Ends -
For more information, please contact:
Assura plc |
Tel: 01925 420660 |
Orla Ball Carolyn Jones |
|
Finsbury |
Tel: 0207 251 3801 |
Gordon Simpson |
|
Notes to Editors
Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2016, Assura's property portfolio was valued at £1,111 million.
Further information is available at www.assuraplc.com